instance, we have previously demonstrated that iron overload We investigated the effects of a new iron chelator, Oincreased DNA synthesis and mitotic index in primary cultures Trensox (TRX), compared with desferrioxamine (DFO), of rat hepatocytes stimulated by growth factors (3) . Several on proliferation and apoptosis in cultures of the human studies have also shown that iron overload is implicated in hepatoblastoma HepG2 and hepatocarcinoma HBG cell tumor cell growth in vivo (4,5) and the risk of developing an lines. Our results show that TRX decreased DNA synthesis HCC seems to be related to the level and duration of iron in a time-and dose-dependent manner and with a higher overload (6,7).
efficiency than DFO. Mitotic index was also strongly
There is great interest in developing new efficient and nondecreased by TRX and, unexpectedly, DFO inhibited toxic iron chelators in order to decrease iron overload in both mitotic activity to the same extent as TRX, thus there is a genetic and secondary hemochromatosis. Iron depletion by discrepancy between the slight reduction in DNA synthesis chelators has been shown to inhibit proliferation of various and a large decrease in mitotic index after DFO treatment.
cell lines and normal activated lymphocytes in vitro (8-10). In In addition, we found that TRX induced accumulation of our laboratory we have also demonstrated that desferrioxamine cells in the G 1 and G 2 phases of the cell cycle whereas DFO (DFO) and hydroxypyridin-4-ones decrease DNA synthesis in arrested cells in G 1 and during progression through S both normal and transformed hepatocytes (11,12).
phase. These data suggest that the partial inhibition of
Cell cycle studies have shown that chelator-treated cells are DNA replication observed after exposure to DFO may be arrested in different phases of the cell cycle depending upon due to a lower efficiency of metal chelation and/or that it the cell type and the concentration and time of exposure to does not inhibit the G 1 /S transition but arrests cells in late chelators (13-15). Moreover, several authors have reported S phase. The effects of both TRX and DFO on DNA that iron chelators induce apoptosis in proliferating cells such synthesis and mitotic index were reversible after removing as activated T lymphocytes and promyelocytic HL60 and the chelators from the culture medium. An apoptotic effect murine lymphoma 38C13 cells (16, 17) . Thus, iron chelators of TRX was strongly suggested by analysis of DNA content have been proposed as promising antiproliferative agents in by flow cytometry, nuclear fragmentation and DNA the treatment of human cancers. degradation in oligonucleosomes and confirmed by the We previously reported iron mobilization by and a protective induction of a high level of caspase 3-like activity. TRX effect on hepatocytes against iron toxicity of a new iron induced apoptosis in a dose-and time-dependent manner chelator, O-Trensox (TRX) (18). TRX is a synthetic, water in proliferating HepG2 cells. In HBG cells, TRX induced soluble, tripodal iron-sequestering agent constituted of three apoptosis in proliferating and confluent cells arrested in molecules of 8-hydroxyquinoline connected together by approthe G 1 phase of the cell cycle, demonstrating that inhibition priate linker groups. This chelator can bind both ferric (Fe 3ϩ ) of proliferation and induction of apoptosis occurred indeand ferrous (Fe 2ϩ ) ions and zinc but does not induce radical pendently. DFO induced DNA alterations only at concentradamage (18) (19) (20) . In order to determine whether TRX can tions Ͼ100 µM and without induction of caspase 3-like affect growth and survival of hepatic cells, we investigated activity, indicating that DFO is not a strong inducer of its effects on proliferation and cell death in the human apoptosis. Addition of Fe or Zn to the culture medium hepatoblastoma HepG2 and hepatocarcinoma HBG cell lines. during TRX treatment led to a complete restoration of proliferation rate and inhibition of apoptosis, demonstrating that Fe/Zn-saturated TRX was not toxic in the absence Materials and methods of metal depletion. These data show that TRX, at concentra- was established in our laboratory and was recently described (22). Both cell lines were maintained in the following medium: 75% minimum essential medium, 25% medium 199 (Hank's salts) supplemented with 10% fetal calf serum (FCS) and containing, per ml, 7.5 IU penicillin, 5 µg bovine insulin, Abbreviations: BrdU, 5-bromo-2Ј-deoxyuridine; DFO independent experiments were performed and gave similar results. DNA damage evaluated by DNA fragmentation DNA isolation was performed using a Nucleon BACC kit for the extraction of caspase activity, an inhibitor of caspase activity (DEVD-CHO, a non fluorescent genomic DNA from animal cell cultures (Amersham, Les Ulis, France). Briefly, substrate) was used to perform a competitive assay with DEVD-AMC. DEVDcells were lysed, treated with RNase solution (50 µg/ml) and deproteinized with AMC caspase activity is not totally specific for caspase 3 (23) since other sodium perchlorate solution. DNA was precipitated successively by Nucleon caspases can cleave the DEVD-AMC substrate, but with a much lower efficiency. resin and cold absolute ethanol. Finally, DNA was collected by centrifugation, This activity is usually presented as DEVD-AMC caspase 3-like activity. washed twice with cold 70% (v/v) ethanol, dried and resuspended in 10 mM Statistics Tris-HCl, 1 mM EDTA, pH 8. DNA samples of 10 µg were loaded onto 1% agarose gels containing 0.1 µg/ml ethidium bromide and electrophoresis was Results were expressed as means Ϯ SD. Statistical analyses were performed performed for 1 h at 60 V. A 1 kb DNA ladder (Gibco, Cergy-Pontoise, France) using Student's t-test. The significance level was set at 0.05. was used as a molecular weight marker. DNA was visualized under UV light.
Nuclear fragmentation visualized by Hoechst staining

Results
This detection is based on DNA staining by Hoechst 33258, a specific were actually arrested in the G 2 phase. After 48 h exposure to 50 µM DFO (Figure 3b and d) , a significant increase in the cell The decrease in DNA synthesis in HepG2 cells observed in the presence of TRX was followed by a large decrease in the number in S phase was observed along with a large decrease in cells in G 2 /M phase. mitotic index (Figure 2b ). After 48 h in the presence of 50 µM TRX, an 8-fold decrease in the number of mitoses was observed
TRX inhibits HepG2 cell proliferation
We have shown (Figures 1 and 2 ) that the inhibition of proliferation induced by DFO and TRX is reversible. We confirmed compared with untreated cells (P Ͻ 0.001; Figure 2b ). Incubation with DFO led to a large reduction in mitotic activity, similar to reversion of these effects by analyzing DNA content by flow cytometry (Figure 3d, reversion) . Forty-eight hours after TRX the decrease observed with TRX but in contrast to the partial inhibition of DNA replication (Figures 1a and 2a) .
withdrawal, the number of cells in the S and G 2 /M phases was increased compared with 48 h treated cultures, while the percentInhibition of mitotic activity by the chelators was progressively reversible following their removal from the culture age of cells in G 1 was decreased. In cultures which had been incubated with DFO, 48 h after removing the chelator more than medium. The mitotic index began to increase 24 h after removal and reached 70 and 50% of the control value with DFO and 50% of cells were in G 2 and only 22% in S phase. These results lead us to conclude that TRX and DFO strongly TRX, respectively, after 48 h (P Ͻ 0.001; Figure 2b ). As observed with DNA replication (Figures 1b and 2a) , reversion of mitotic inhibit proliferation of HepG2 cells but arrest these cells at different steps in the cell cycle: TRX mainly arrests cells in the inhibition occurred more rapidly after DFO than TRX withdrawal. The first evidence that TRX could trigger HepG2 cell death was the fact that a large peak of cells of low DNA content HepG2 cells treated or not with these chelators by flow cytometry. A typical experiment is shown in Figure 3a -c and results of was detected by flow cytometry after 72 h treatment at 100 µM and to a much lesser extent at 50 and 20 µM (Figure 4a ). four distinct experiments are presented in Figure 3d . In DFO-treated cells, no similar peak of dead cells was observed DNA degradation in oligonucleosomes and activation of cysteine aspartate proteases (caspases) specifically induced during during the 3 days culture with comparable concentrations of chelator (data not shown). This cell death induced by TRX the final step of the hepatocyte apoptotic process (24) .
In situ nuclear fragmentation was demonstrated in cultures was confirmed by significant dose-dependent LDH release into the culture medium after 72 h exposure to the chelator treated with TRX by staining HepG2 cells with Hoechst 33258 (Figure 5a, inset) . We established the index of cells with compared with untreated cultures (P Ͻ 0.001; Figure 4b) . Analysis of DNA content by flow cytometry and evaluation fragmented nuclei for 72 h treatment with several doses of TRX (Figure 5a ). No cells with a fragmented nucleus were of LDH release, at least under our conditions, did not allow us to definitely conclude that TRX-mediated cell death was observed after 12 h exposure to 20, 50 or 100 µM; a few positive cells were observed after 24 h incubation in the due to apoptosis. Therefore, we examined three criteria considered to characterize apoptosis: in situ nuclear fragmentation, presence of 50 and 100 µM TRX. The number increased with time of culture in a dose-dependent manner, the highest index with higher concentrations (Figure 5b ) and longer times after or TRX (20, 50 and 100 µM) for 2 and 3 days or Fas-activating antibody (200 ng/ml) and cycloheximide (10 µg/ml) for 6 h. Two independent a 48 h incubation with 50 and 100 µM TRX, but not with experiments gave similar results.
DNA fragmentation induced at 20 µM (data not shown).
In contrast, we did not obtain any evidence of HepG2 apoptosis after a 3 day DFO treatment at concentrations up to induced during the apoptotic process in many eukaryotic cells, including hepatocytes (23, 24) . Caspase 3-like activity was 100 µM, neither by flow cytometry nor after in situ Hoechst staining. We tested whether a higher concentration (200 µM) significantly induced after TRX treatment in a dose-and time-dependent manner (Figure 5c ), demonstrating that TRXcould induce HepG2 cell death. Analysis of DNA fragmentation clearly demonstrated the appearance of DNA alterations in mediated cell death was due to apoptosis. In contrast, DFO did not significantly increase caspase 3-like activity even at genomic DNA of HepG2 cells at this high concentration (Figure 5b) . 200 µM after 3 days treatment. As a positive control for apoptosis, we used a monoclonal Fas-activating antibody In order to definitely conclude that cell death observed after TRX and DFO treatment was due to apoptosis, we assayed (200 ng/ml) combined with cycloheximide (10 µg/ml), strong apoptotic inducers in hepatic cells (24) . This apoptotic signal, caspase 3-like activity, which is a specific protease activity which induced caspase 3-like activity within 6 h (Figure 5d ), led to more than 95% cell death within 24 h (data not shown). It is interesting to note that the value of Fas-activating antibody/ cycloheximide-induced caspase 3-like activity was only twice the activity measured in cells treated with 100 µM TRX for 3 days, demonstrating that TRX is a potent apoptosis inducer.
Cell cycle arrest and apoptosis induced by TRX are due to metal depletion
To rule out the hypothesis that cell cycle arrest and apoptosis induced by TRX could be due to a toxic effect of the molecule unrelated to metal chelation, we treated HepG2 cells with TRX in the presence of Fe citrate or ZnCl 2 and measured [ 3 H]methylthymidine incorporation and caspase 3-like activity (Figure 6 ). Two different protocols were used: (i) 50 µM TRX simultaneously with Fe or Zn (50 µM) for 2 or 3 days ( Figure  6a and b) ; (ii) 50 µM TRX for 2 days, then Fe or Zn (12 µM) in the absence of TRX for 1 (Figure 6c ) or 2 more days (Figure 6b ). These two experiments were performed to test the toxicity of Fe-and Zn-saturated TRX for 3 days (TRX toxicity in the absence of metal depletion) and to determine whether, after 2 days metal depletion by TRX, the addition of Fe or Zn at a low concentration was able to inhibit cell death at day 3 ( Figure 5 ) and restore proliferation between days 3 and 4, as observed in the reversion experiments (Figures 1-3) , respectively.
Several important conclusions could be drawn from these experiments: These results demonstrate that TRX is not toxic per se and that inhibition of proliferation and induction of apoptosis by if cell death occurred independently of this inhibition of TRX are due to metal depletion.
proliferation.
Cell cycle arrest and apoptosis are two independent con-
To address this issue, HepG2 cells could not be used since, sequences of TRX treatment at confluency, they grow continuously, indicating loss of cellOur results demonstrate that metal depletion by TRX leads to cell contact inhibition, then rapidly detach and die. Therefore, inhibition of cell proliferation and induction of apoptosis.
we decided to use the HBG hepatocarcinoma cell line, which However, these experiments did not allow us to determine has been established in our laboratory and was recently described (22). HBG cells are characterized by the fact that whether apoptosis was a consequence of cell cycle arrest or and apoptosis are two independent consequences of TRX treatment.
Discussion
Iron is implicated particularly in DNA replication, and cellular depletion of this metal is a potent way to reduce cell proliferation (8-12). Very few data have been published concerning the molecular basis of the inhibitory effects of iron chelators on proliferation. However, it has been shown that iron depletion arrests human neuroblastoma cells in late G 1 phase of the cell cycle (25) and breast cancer cells at the G 1 /S transition (15) and that this effect is mediated through inhibition of the expression of cyclin A and/or induction of cyclin-dependent kinase complexes such as cyclin D1/cdk4 (15) .
In order to determine whether TRX can also affect the growth of hepatoma cells, we evaluated its effects on proliferation of the human hepatoblastoma HepG2 cell line. Here we show that TRX is a potent inhibitor of HepG2 cell proliferation, strongly decreasing DNA replication and mitotic activity and arresting the cell cycle in the G 1 and G 2 phases.
DFO, which was used as a reference iron chelator, slightly reduces DNA replication but induces a strong inhibition of HepG2 cell mitotic activity, arresting cells in G 1 and/or S phase. Two hypotheses can be proposed to explain why DFO only slightly decreases DNA replication after 48 h transition but arrests HepG2 cells at different steps during S phase progression, indicating that some cells partially replicate DNA before arrest. they are poorly differentiated during proliferation at low cell density while they stop proliferating at confluency, remain These hypotheses are both supported by two additional observations; a decrease in [ 3 H]methylthymidine incorporaarrested in G 1 phase and undergo progressive differentiation leading to the expression of many hepatocyte-specific functions tion in DFO-treated HepG2 cells between 48 and 72 h ( Figure 1a ); the remaining [ 3 H]methylthymidine incorporation (22). In addition, they can be maintained at confluency and in a differentiated state for weeks without cell death. Therefore, in HepG2 cells treated with DFO for 72 h, which is much higher than incorporation measured in cells exposed to TRX, HBG cells appeared to be the most suitable cell system to distinguish between the effects of TRX on proliferation and while in both conditions mitotic activity is very low (Figure 2b ). apoptosis.
We confirmed that a 2 day treatment with TRX (50 µM) Another striking result is the difference in profiles of DNA content in TRX-and DFO-treated cells. Our results significantly decreased [ 3 H]methylthymidine incorporation ( Figure 7a ) and induced apoptosis (Figure 7b ) in proliferating strongly suggest that these two metal chelators act on cell cycle progression via distinct mechanisms and/or chelate HBG cell cultures. Addition of Fe or Zn (50 µM) to the culture medium simultaneously with TRX (50 µM) restored intracellular metal pools with different efficiency. Distinct effects of metal chelators on cellular functions, and even increased DNA replication and totally inhibited caspase 3-like activity, as previously observed in HepG2 especially cell proliferation, have been reported previously. The antiproliferative effect of iron chelators most likely cells. We then maintained HBG cell cultures at confluency for 3 weeks until [ 3 H]methylthymidine incorporation decreased triggers inhibition of ribonucleotide reductase (RR), which is iron dependent and crucial for deoxynucleotide synthesis (Figure 7a ) and studied whether TRX induced apoptosis in these non-proliferating cells. As shown in Figure 7b, To further progress the characterization of TRX effects, with increases in DNA synthesis in the surrounding cirrhosis.
we studied whether the antiproliferative effect of TRX Gastroenterology, 103, 595-600.
observed in HepG2 cells, and the subsequent cell cycle 7. Ballardini,G., Groff,P., Zoli,M., Bianchi,G., Giostra,F., Francesconi,R., arrest, is followed by or concomitant with cell death. In DNA alterations occur without significant caspase 3-like 11. Chenoufi,N., Baffet,G., Drénou,B., Cariou,S., Desille,M., Clément,B., activation, suggesting that DFO-mediated cell death is due
